Artwork

Contenido proporcionado por Web Summit. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Web Summit o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

The quest for human immortality

22:41
 
Compartir
 

Manage episode 378634628 series 1409459
Contenido proporcionado por Web Summit. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Web Summit o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Beyond the indulgences of tech billionaires including Bryan Johnson – who has spent millions on longevity interventions (including plasma infusions from a teenage son) – can the rest of us expect to live into our hundreds?

Amol Sarva, founder of a venture fund investing in longevity research, and Joel Jackson, co-founder and president of a healthtech company trying to extend lifespans, discuss how tech advances including AI and personalised medicine could help extend life spans to 150 years or more.

Amol and Joel explore recent progress in targeting diseases of ageing, as well as fundamental biological ageing. While human immortality in 20 years seems unlikely, breakthroughs that slow the ageing process are possible. But ethical questions remain around fair access.

Amol Sarva, managing partner at Life Extension Ventures, and Joel Jackson, co-founder and president of Lifeforce, were in conversation with Yuliya Sotska, chief brand and communications officer for Viseven, on HealthConf at Collision 2023.

  continue reading

276 episodios

Artwork
iconCompartir
 
Manage episode 378634628 series 1409459
Contenido proporcionado por Web Summit. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Web Summit o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

Beyond the indulgences of tech billionaires including Bryan Johnson – who has spent millions on longevity interventions (including plasma infusions from a teenage son) – can the rest of us expect to live into our hundreds?

Amol Sarva, founder of a venture fund investing in longevity research, and Joel Jackson, co-founder and president of a healthtech company trying to extend lifespans, discuss how tech advances including AI and personalised medicine could help extend life spans to 150 years or more.

Amol and Joel explore recent progress in targeting diseases of ageing, as well as fundamental biological ageing. While human immortality in 20 years seems unlikely, breakthroughs that slow the ageing process are possible. But ethical questions remain around fair access.

Amol Sarva, managing partner at Life Extension Ventures, and Joel Jackson, co-founder and president of Lifeforce, were in conversation with Yuliya Sotska, chief brand and communications officer for Viseven, on HealthConf at Collision 2023.

  continue reading

276 episodios

Todos los episodios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida

Escucha este programa mientras exploras
Reproducir